Efficacy and safety of irinotecan monotherapy as third-line treatment for advanced gastric cancer

被引：0
|
作者：
Takeshi Kawakami
Nozomu Machida
Hirofumi Yasui
Masahiro Kawahira
Sadayuki Kawai
Yosuke Kito
Yukio Yoshida
Satoshi Hamauchi
Takahiro Tsushima
Akiko Todaka
Tomoya Yokota
Kentaro Yamazaki
Akira Fukutomi
Yusuke Onozawa
机构：
[1] Shizuoka Cancer Center,Department of Gastrointestinal Oncology
[2] Shizuoka Cancer Center,Department of Clinical Oncology
来源：
Cancer Chemotherapy and Pharmacology | 2016年 / 78卷
关键词：
Advanced gastric cancer; Irinotecan; Third-line treatment; Salvage line;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：809 / 814
页数：5
相关论文
共 50 条
  • [1] Efficacy and safety of irinotecan monotherapy as third-line treatment for advanced gastric cancer
    Kawakami, Takeshi
    Machida, Nozomu
    Yasui, Hirofumi
    Kawahira, Masahiro
    Kawai, Sadayuki
    Kito, Yosuke
    Yoshida, Yukio
    Hamauchi, Satoshi
    Tsushima, Takahiro
    Todaka, Akiko
    Yokota, Tomoya
    Yamazaki, Kentaro
    Fukutomi, Akira
    Onozawa, Yusuke
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (04) : 809 - 814
  • [2] Efficacy and safety of irinotecan monotherapy as third line treatment for advanced gastric cancer
    Kawakami, Takeshi
    Machida, Nozomu
    Kawahira, Masahiro
    Kawai, Sadayuki
    Kito, Yosuke
    Yoshida, Yukio
    Hamauchi, Satoshi
    Tsushima, Takahiro
    Todaka, Akiko
    Yamazaki, Kentaro
    Yokota, Tomoya
    Fukutomi, Akira
    Onozawa, Yusuke
    Yasui, Hirofumi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [3] Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer
    Akitaka Makiyama
    Kohei Arimizu
    Gen Hirano
    Chinatsu Makiyama
    Yuzo Matsushita
    Tsuyoshi Shirakawa
    Hirofumi Ohmura
    Masato Komoda
    Keita Uchino
    Kyoko Inadomi
    Shuji Arita
    Hiroshi Ariyama
    Hitoshi Kusaba
    Yudai Shinohara
    Miyuki Kuwayama
    Tatsuhiro Kajitani
    Hisanobu Oda
    Taito Esaki
    Koichi Akashi
    Eishi Baba
    [J]. Gastric Cancer, 2018, 21 : 464 - 472
  • [4] Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer
    Makiyama, Akitaka
    Arimizu, Kohei
    Hirano, Gen
    Makiyama, Chinatsu
    Matsushita, Yuzo
    Shirakawa, Tsuyoshi
    Ohmura, Hirofumi
    Komoda, Masato
    Uchino, Keita
    Inadomi, Kyoko
    Arita, Shuji
    Ariyama, Hiroshi
    Kusaba, Hitoshi
    Shinohara, Yudai
    Kuwayama, Miyuki
    Kajitani, Tatsuhiro
    Oda, Hisanobu
    Esaki, Taito
    Akashi, Koichi
    Baba, Eishi
    [J]. GASTRIC CANCER, 2018, 21 (03) : 464 - 472
  • [5] Irinotecan monotherapy as third-line treatment for advanced gastric cancer refractory to fluoropyrimidines, platinum, and taxanes
    Nishimura, Takashi
    Iwasa, Satoru
    Nagashima, Kengo
    Okita, Natsuko
    Takashima, Atsuo
    Honma, Yoshitaka
    Kato, Ken
    Hamaguchi, Tetsuya
    Yamada, Yasuhide
    Shimada, Yasuhiro
    Boku, Narikazu
    [J]. GASTRIC CANCER, 2017, 20 (04) : 655 - 662
  • [6] Irinotecan monotherapy as third-line treatment for advanced gastric cancer refractory to fluoropyrimidines, platinum, and taxanes
    Takashi Nishimura
    Satoru Iwasa
    Kengo Nagashima
    Natsuko Okita
    Atsuo Takashima
    Yoshitaka Honma
    Ken Kato
    Tetsuya Hamaguchi
    Yasuhide Yamada
    Yasuhiro Shimada
    Narikazu Boku
    [J]. Gastric Cancer, 2017, 20 : 655 - 662
  • [7] Association between UGT1A1 gene polymorphism and safety and efficacy of irinotecan monotherapy as the third-line treatment for advanced gastric cancer
    Toshifumi Yamaguchi
    Satoru Iwasa
    Hirokazu Shoji
    Yoshitaka Honma
    Atsuo Takashima
    Ken Kato
    Tetsuya Hamaguchi
    Kazuhide Higuchi
    Narikazu Boku
    [J]. Gastric Cancer, 2019, 22 : 778 - 784
  • [8] Association between UGT1A1 gene polymorphism and safety and efficacy of irinotecan monotherapy as the third-line treatment for advanced gastric cancer
    Yamaguchi, Toshifumi
    Iwasa, Satoru
    Shoji, Hirokazu
    Honma, Yoshitaka
    Takashima, Atsuo
    Kato, Ken
    Hamaguchi, Tetsuya
    Higuchi, Kazuhide
    Boku, Narikazu
    [J]. GASTRIC CANCER, 2019, 22 (04) : 778 - 784
  • [9] Efficacy of Irinotecan as Third-line Chemotherapy for Unresectable or Recurrent Gastric Cancer
    Fukuchi, Minoru
    Kuwabara, Kohki
    Ishiguro, Toru
    Kumagai, Youichi
    Ishibashi, Keiichiro
    Mochiki, Erito
    Ishida, Hideyuki
    [J]. IN VIVO, 2020, 34 (02): : 903 - 908
  • [10] Efficacy and safety of nivolumab and irinotecan as third-line chemotherapy for advanced gastric cancer: A multi-institutional retrospective study
    Kumanishi, Ryosuke
    Mitani, Seiichiro
    Kadowaki, Shigenori
    Matsushima, Tomohiro
    Takahashi, Naoki
    Ogata, Takatsugu
    Yasui, Hisateru
    Ogata, Misato
    Satake, Hironaga
    Narita, Yukiya
    Masuishi, Toshiki
    Bando, Hideaki
    Hara, Hiroki
    Muro, Kei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
12345